News
Combined Company Expected to be Listed on NASDAQ Global Market DRC Medicine Ltd. (“DRC Medicine” or the “Company”), is an innovative healthcare and biotechnology company headquartered in Japan, ...
The FDA's breakthrough devices program helps the industry with faster review times, but the benefit to patients is unclear.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback